Concourse Financial Group Securities’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 9704 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 9732 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 9631 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 9305 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9081 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 8863 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8643 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8432 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8117 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8127 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7958 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7823 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7683 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7538 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7273 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6999 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6731 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6516 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6298 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6144 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6054 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5970 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5817 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5831 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5727 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5643 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5482 |
|